Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-13 Purchase |
2025-05-15 6:48 pm |
Apimeds Pharmaceuticals US Inc. | APUS | Kim Christopher Chairman and CMO |
27,500 | $1.8312 | $50,359 | 27,500 (Direct) |
View |
| 2025-05-12 Purchase |
2025-05-14 5:58 pm |
Apimeds Pharmaceuticals US Inc. | APUS | Koo Jakap Director |
28,500 | $1.99 | $56,715 | 643,885 (Direct) |
View |
| 2025-05-12 Purchase |
2025-05-14 5:52 pm |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
500,000 | $4 | $2,000,000 | 6,416,365 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-12 Conversion(A) |
2025-06-11 4:36 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
115,131 | $2.6 | 2,099,747 (Direct) |
View |
| 2025-05-12 Conversion(A) |
2025-06-11 4:36 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
299,340 | $0 | 2,099,747 (Direct) |
View |
Ownership(A) |
2025-06-11 4:11 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
0 | $0 | 6,391,777 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 5:18 pm |
N/A 2035-05-16 |
Apimeds Pharmaceuticals US Inc. | APUS | Kogan Elona Director |
5,780 | $0 | 5,780 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 5:11 pm |
N/A 2035-05-16 |
Apimeds Pharmaceuticals US Inc. | APUS | Yoon Hankil Director |
5,780 | $0 | 5,780 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 5:02 pm |
N/A 2035-05-16 |
Apimeds Pharmaceuticals US Inc. | APUS | O'DONNELL CAROL A Director |
5,780 | $0 | 5,780 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 5:00 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Kim Christopher Chairman and CMO |
250,000 | $0 | 277,500 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 4:56 pm |
N/A 2035-05-16 |
Apimeds Pharmaceuticals US Inc. | APUS | Emerson Erik C. Chief Executive Officer |
1,097,279 | $0 | 1,097,279 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 4:46 pm |
N/A 2035-05-16 |
Apimeds Pharmaceuticals US Inc. | APUS | Weintraub Bennett Director |
5,780 | $0 | 5,780 (Direct) |
View |
| 2025-05-16 Option Award |
2025-05-20 4:38 pm |
N/A 2035-05-16 |
Apimeds Pharmaceuticals US Inc. | APUS | Koo Jakap Director |
5,780 | $0 | 5,780 (Direct) |
View |
| 2025-05-12 Conversion |
2025-05-14 5:52 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
297,133 | $2.6 | 6,416,365 (Indirect) |
View |
| 2025-05-12 Conversion |
2025-05-14 5:52 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
772,545 | $0 | 6,416,365 (Indirect) |
View |
Ownership(A) |
2025-05-14 5:32 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
0 | $0 | 6,391,777 (Direct) |
View |
Ownership |
2025-05-08 5:31 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Koo Jakap Director |
0 | $0 | 615,385 (Direct) |
View |
Ownership |
2025-05-08 5:19 pm |
N/A N/A |
Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner |
0 | $0 | 5,619,234 (Direct) |
View |
Ownership |
2025-05-08 5:06 pm |
N/A 2030-05-12 |
Apimeds Pharmaceuticals US Inc. | APUS | Kim Christopher Chairman and CMO |
0 | $0 | 213,692 (Direct) |
View |